Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05295823 · ClinicalTrials.gov registry record · NA
Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound
A NA study of Voiding Dysfunction and Voiding Disorders, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05295823: Completed NA study of Voiding Dysfunction and Voiding Disorders, sponsored by Yale University.
NCT05295823 is a NA study of Voiding Dysfunction and Voiding Disorders that has completed, run by Yale University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05295823, a NA study of Voiding Dysfunction and Voiding Disorders, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study would be the first to demonstrate feasibility, accuracy, reliability, clinical care impact, and patient satisfaction with remote monitoring of post-void residual bladder volume (PVR) using the Butterfly portable ultrasound device in patients with obstructive voiding dysfunction.
Primary Outcome
Accuracy of the patient self-measurement of PVR using the Butterfly portable ultrasound device with bladder ultrasound images compared to the Butterfly portable ultrasound device with abstract bladder images during the same encounter. It is measured by Bland-Altman analysis which describes agreement between two quantitative measurements. More agreement means less difference between measurements.
Conditions Studied
Interventions
- DEVICE Butterfly portable ultrasound device with bladder ultrasound images
- DEVICE Butterfly portable ultrasound device with abstract bladder images
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-04-27 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
What the finished NCT05295823 record still lists
NCT05295823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Voiding Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Butterfly portable ultrasound device with bladder ultrasound images is the first listed.
NCT05295823 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05295823 about?
NCT05295823 is a clinical study titled "Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound". This study would be the first to demonstrate feasibility, accuracy, reliability, clinical care impact, and patient satisfaction with remote monitoring of post-void residual bladder volume (PVR) using the Butterfly portable ultrasound device in patients with obstructive voiding dysfunction.
What is the current status of trial NCT05295823?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-04-27. Estimated completion is 2022-06-03.
What conditions does trial NCT05295823 study?
This clinical trial studies the following conditions: Voiding Dysfunction, Voiding Disorders.
What interventions are being tested in trial NCT05295823?
The interventions under investigation include: Butterfly portable ultrasound device with bladder ultrasound images (DEVICE), Butterfly portable ultrasound device with abstract bladder images (DEVICE).
Who is sponsoring clinical trial NCT05295823?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05295823 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Voiding Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05295823's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI